These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 31257348)
21. Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report. Toyonaga H; Fukushima M; Shimeno N; Inokuma T BMC Gastroenterol; 2019 Apr; 19(1):62. PubMed ID: 31023238 [TBL] [Abstract][Full Text] [Related]
22. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate. Saito S; Kaneko Y; Yamaoka K; Tokuhira M; Takeuchi T Rheumatology (Oxford); 2017 Jun; 56(6):940-946. PubMed ID: 28165538 [TBL] [Abstract][Full Text] [Related]
24. Analysis of Notch1 protein expression in methotrexate-associated lymphoproliferative disorders. Okatani T; Nishimura MF; Egusa Y; Yoshida S; Nishimura Y; Nishikori A; Yoshino T; Yamamoto H; Sato Y J Clin Exp Hematop; 2024 Mar; 64(1):1-9. PubMed ID: 38281745 [TBL] [Abstract][Full Text] [Related]
25. Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases. Yasuda H; Ando J; Yoshida S; Ota Y; Komatsu N; Ando M Intern Med; 2023 Feb; 62(4):601-604. PubMed ID: 35793959 [TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature. He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145 [TBL] [Abstract][Full Text] [Related]
28. Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders. Nakano K; Saito K; Nawata A; Hanami K; Kubo S; Miyagawa I; Fujino Y; Nakayamada S; Tanaka Y Mod Rheumatol; 2021 Jan; 31(1):94-100. PubMed ID: 32159414 [TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders. Tokuhira M; Saito S; Suzuki K; Higashi M; Momose S; Shimizu T; Mori T; Kimura Y; Amano K; Okamoto S; Takeuchi T; Tamaru JI; Kizaki M Leuk Lymphoma; 2019 Oct; 60(10):2508-2515. PubMed ID: 30947579 [TBL] [Abstract][Full Text] [Related]
34. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases. Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315 [TBL] [Abstract][Full Text] [Related]
35. Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis. Kitamura N; Sugiyama K; Nagasawa Y; Hamaguchi M; Kobayashi H; Takei M Clin Exp Rheumatol; 2022 Jul; 40(7):1330-1335. PubMed ID: 34369356 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical Assessment of the Diagnostic Utility of PD-L1 (Clone SP142) for Methotrexate-Associated Lymphoproliferative Disorders With an Emphasis of Neoplastic PD-L1 (Clone SP142)-Positive Classic Hodgkin Lymphoma Type. Kohno K; Suzuki Y; Elsayed AA; Sakakibara A; Takahara T; Satou A; Kato S; Nakamura S; Asano N Am J Clin Pathol; 2020 Apr; 153(5):571-582. PubMed ID: 31977037 [TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression. Takanashi S; Aisa Y; Ito C; Arakaki H; Osada Y; Amano Y; Hirano M; Nakazato T Rheumatol Int; 2017 Oct; 37(10):1629-1633. PubMed ID: 28676912 [TBL] [Abstract][Full Text] [Related]
38. Methotrexate-associated Lymphoproliferative Disease with Multiple Pulmonary Nodules in a Patient with Rheumatoid Arthritis. Suemori K; Hasegawa H; Ishizaki J; Matsumoto T; Onishi S; Sada E; Sugita A; Yasukawa M Intern Med; 2015; 54(11):1421-5. PubMed ID: 26028000 [TBL] [Abstract][Full Text] [Related]
39. Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting. Momose S; Tamaru JI J Clin Exp Hematop; 2019; 59(2):48-55. PubMed ID: 31257345 [TBL] [Abstract][Full Text] [Related]
40. Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder, Hodgkin Type, following Epstein-Barr Viral Hepatitis in a Patient with Rheumatoid Arthritis. Saburi M; Ogata M; Yoshida N; Nashimoto Y; Moroga Y; Takano K; Kohno K; Daa T; Shirao K Intern Med; 2018 Apr; 57(8):1145-1149. PubMed ID: 29279493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]